Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts

被引:9
|
作者
Shah, Yajas [1 ,2 ]
Yang, Hua [3 ]
Mueller, Franco B. [3 ]
Li, Carol [3 ]
Rahim, Shab E. Gul [3 ]
Varma, Elly [3 ]
Salinas, Thalia [3 ,4 ]
Dadhania, Darshana M. [3 ,4 ]
Salvatore, Steven P. [5 ]
Seshan, Surya, V [5 ]
Sharma, Vijay K. [3 ]
Elemento, Olivier [1 ,2 ]
Suthanthiran, Manikkam [3 ,4 ]
Muthukumar, Thangamani [3 ,4 ,6 ]
机构
[1] Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY USA
[2] Weill Cornell Med Coll, Grad Program Physiol Biophys & Syst Biol, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, New York, NY USA
[4] NewYork Presbyterian Weill Cornell Med Ctr, Dept Transplantat Med, New York, NY USA
[5] Weill Cornell Med Coll, Dept Pathol & Lab Med, Div Renal Pathol, New York, NY USA
[6] Weill Cornell Med Coll, Dept Med, Div Nephrol & Hypertens, 525 East 68th St,Box 3, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
chronic active antibody-mediated rejection; kidney biopsy; kidney transplantation; natural killer cells; RNA sequencing; DONOR-SPECIFIC ANTIBODIES; NK CELLS; MOLECULAR DIAGNOSIS; INVOLVEMENT; MECHANISMS; RECIPIENTS; BIOPSIES; INJURY;
D O I
10.1016/j.kint.2023.11.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Natural killer (NK) cells mediate spontaneous cell -mediated cytotoxicity and antibody -dependent cell -mediated cytotoxicity. This dual functionality could enable their participation in chronic active antibody -mediated rejection (CA-ABMR). Earlier microarray profiling studies have not subcategorized antibody -mediated rejection into CA-ABMR and active-ABMR, and the gene expression pattern of CAABMR has not been compared with that of T cell -mediated rejection (TCMR). To fill these gaps, we RNA sequenced human kidney allograft biopsies categorized as CA-ABMR, active-ABMR, TCMR, or No Rejection (NR). Among the 15,910 genes identified in the biopsies, 60, 114, and 231 genes were uniquely overexpressed in CA-ABMR, TCMR, and active-ABMR, respectively; compared to NR, 50 genes were shared between CA-ABMR and active-ABMR, and 164 genes between CA-ABMR and TCMR. The overexpressed genes were annotated to NK cells and T cells in CA-ABMR and TCMR, and to neutrophils and monocytes in activeABMR. The NK cell cytotoxicity and allograft rejection pathways were enriched in CA-ABMR. Genes encoding perforin, granzymes, and death receptor were overexpressed in CA-ABMR versus active-ABMR but not compared to TCMR. NK cell cytotoxicity pathway gene set variation analysis score was higher in CA-ABMR compared to active-ABMR but not in TCMR. Principal component analysis of the deconvolved immune cellular transcriptomes separated CA-ABMR and TCMR from activeABMR and NR. Immunohistochemistry of kidney allograft biopsies validated a higher proportion of CD56D NK cells in CA-ABMR than in active-ABMR. Thus, CA-ABMR was exemplified by the overexpression of the NK cell cytotoxicity pathway gene set and, surprisingly, molecularly more like TCMR than active-ABMR.
引用
收藏
页码:347 / 363
页数:17
相关论文
共 50 条
  • [1] Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts
    Baldwin, William M., III
    Valujskikh, Anna
    Fairchild, Robert L.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2016, 21 (01) : 7 - 14
  • [2] The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts
    Haas, Mark
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (12) : 2849 - 2856
  • [3] Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts
    Haas, Mark
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (03) : 137 - 143
  • [4] Human Pooled Immunoglobulin as Treatment of Active Antibody-Mediated Rejection of Transplanted Kidney
    Furmanczyk-Zawiska, A.
    Urbanowicz, A.
    Perkowska-Ptasinska, A.
    Baczkowska, T.
    Sadowska, A.
    Nazarewski, S.
    Chmura, A.
    Durlik, M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (05) : 1446 - 1450
  • [5] Current problems of chronic active antibody-mediated rejection
    Takeda, Asami
    Horike, Keiji
    Ohtsuka, Yasuhiro
    Inaguma, Daijo
    Goto, Norihiko
    Watarai, Yoshihiko
    Uchida, Kazuharu
    Morozumi, Kunio
    CLINICAL TRANSPLANTATION, 2011, 25 : 2 - 5
  • [6] Mesangiolysis in Chronic Active Antibody-mediated Rejection in Kidney Transplant Biopsies
    Suto, Yuki
    Oguchi, Hideyo
    Tochigi, Naobumi
    Mikami, Tetuo
    Shinoda, Kazunobu
    Honda, Kazuho
    Kounoue, Noriyuki
    Hashimoto, Junya
    Muramatsu, Masaki
    Itabashi, Yoshihiro
    Sakai, Ken
    NEPHRON, 2023, : 14 - 21
  • [7] Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies
    Callemeyn, Jasper
    Lerut, Evelyne
    de Loor, Henriette
    Arijs, Ingrid
    Thaunat, Olivier
    Koenig, Alice
    Meas-Yedid, Vannary
    Olivo-Marin, Jean-Christophe
    Halloran, Philip
    Chang, Jessica
    Thorrez, Lieven
    Kuypers, Dirk
    Sprangers, Ben
    Van Lommel, Leentje
    Schuit, Frans
    Essig, Marie
    Gwinner, Wilfried
    Anglicheau, Dany
    Marquet, Pierre
    Naesens, Maarten
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (09): : 2168 - 2183
  • [8] Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantation
    Nickerson, Peter W. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 38 - 44
  • [9] Antibody-Mediated Rejection of Renal Allografts: Diagnostic Pitfalls and Challenges
    Novotny, Marek
    Kment, Martin
    Viklicky, Ondrej
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S551 - S565
  • [10] Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
    Sablik, Kasia A.
    Jordanova, Ekaterina S.
    Pocorni, Noelle
    Clahsen-van Groningen, Marian C.
    Betjes, Michiel G. H.
    FRONTIERS IN IMMUNOLOGY, 2020, 10